Biological therapy in inflammatory bowel diseases: Access in Central and Eastern Europe

Figure 2 Average number of Crohn's disease patients treated with biologicals per 10⁵ inhabitants compared to countries per capita total expenditure on health. Ulcerative colitis would display a similar figure. Sizes of bubbles refer to the absolute number of patients treated with biologicals in each country. Data sources: patient numbers: IMS data (2014 or latest available), population data: Eurostat Statistics Database (2013)[34], total health expenditure per capita (2012): World Bank Databank[26]. BGR: Bulgaria; CZE: Czech Republic; EST: Estonia; HUN: Hungary; LVA: Latvia; LTU: Lithuania; POL: Poland; ROM: Romania; SVK: Slovakia.